Sydney to Hobart yacht race: Two sailors killed in separate accidents during night of wild weather
Manchester United ‘just have to survive’ says Ruben Amorim after Wolves loss
Painstaking work to conserve Ireland’s oldest paper documents begins
Cool change slows Grampians bushfire in Victoria as NSW braces for windy day of extreme fire danger
EU should spare carmakers from ‘punitive’ emissions fines, says Scholz
Nice says more evidence needed on effectiveness of tirzepatide, sold under brand name Mounjaro
A weight-loss jab has been rejected for NHS use by England’s drugs watchdog.
The National Institute for Health and Care Excellence (Nice), which provides recommendations and guidance to health practitioners, said further evidence was needed on the clinical and cost-effectiveness of tirzepatide, which is sold under the brand name Mounjaro, before it could be recommended for NHS use.
More Stories
‘Wild west’: experts concerned by illegal promotion of weight-loss jabs in UK
Scientists explore longevity drugs for dogs that could also ‘extend human life’
People urged to do at least 150 minutes of aerobic exercise a week to lose weight